comprehensive -WSS

comprehensive

author：leisure time 2025-10-01 04:13:10 - browse：7556

Teleflex announced plans on Wednesday to acquire Palette Life Sciences, the maker of a slate of gel-based products treating urological disorders. The vascular device manufacturer will pay $600 million upfront, and plans to use Palette’s portfolio to treat more urinary tract and reproductive health conditions.

Palette will bring Teleflex an extra $56 million in sales, the company estimated in a press release. Teleflex develops a range of devices, but makes the most money from vascular products like catheters. The company offers just one urological treatment: the UroLift system to relieve an enlarged prostate. With Palette, it will gain five more treatments all built from hyaluronic acid, a stretchy material that’s meant to last longer in the human body.

Palette’s highest-revenue device is Barrigel, which helps protect the rectum from harsh radiation administered to prostate cancer patients. It eases symptoms like bladder inflammation, bleeding, and diarrhea. The device received FDA clearance in May 2022 through the 510(k) process, which allowed Palette to claim the product was equivalent to a rectal radiation protector sold by Boston Scientific. Boston Scientific has sold that device since 2018, when it acquired it by buying the startup Augmenix for $500 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： What's changing in Medicare's open enrollment this year?

focus

WSS

Plane’s emergency slide plummets from sky, hits Chicago home

STAT Readout: Today's biotech news includes Sana and Amylyx

A revolution in caring for preterm infants

A revolution in caring for preterm infants

Why the Crimean Bridge is key to Russia's war in Ukraine

Better Therapeutics data on benefit with GLP

Wikipedia

comprehensive

hotspot

Alkermes shareholders re

Man who had jail sentence commuted by Trump arrested again

Jerome Adams on the need for new antivirals for Covid

'Reaching a detente': STAT's Helen Branswell on covering Covid

Novavax promises a turnaround & Lilly roils the obesity market

Man who had jail sentence commuted by Trump arrested again

In age of alternative facts, a scholarly course on calling out crap

Peter Marks talks Operation Warp Speed for Rare Diseases

New air purifier tech could be key to improving indoor air quality

How clinical AI models' predictive power can degrade over time

knowledge

European regulators recommend Amylyx's ALS drug be rejected

Celebrate National Dole Whip Day for 3 days this week at Disney

Life sciences deals on track to hit lowest point since 2017

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

There’s no way to know how good AI health technologies are

Lindsay Lohan welcomes 1st child with husband Bader Shammas

entertainment

hotspot

focus

focus